Bo Ahrén
Professor
Publications
Displaying of publications. Sorted by year, then title.
The Glucose Sensitivity of Insulin Secretion-Lessons from In Vivo and In Vitro Studies in Mice
Bo Ahrén
(2022) Biomolecules, 12
Journal articleGlucose-dependent insulinotropic polypeptide secretion after oral macronutrient ingestion : The human literature revisited and a systematic study in model experiments in mice
Bo Ahrén
(2022) Journal of Diabetes Investigation, 13 p.1655-1665
Journal articleAssessing the Effect of Incretin Hormones and Other Insulin Secretagogues on Pancreatic Beta-Cell Function : Review on Mathematical Modelling Approaches
Giovanni Pacini, Bo Ahrén, Christian Göbl, Andrea Tura
(2022) Biomedicines, 10
Journal article reviewTemporal Patterns of Glucagon and Its Relationships with Glucose and Insulin following Ingestion of Different Classes of Macronutrients
Christian Göbl, Micaela Morettini, Benedetta Salvatori, Wathik Alsalim, Hana Kahleova, et al.
(2022) Nutrients, 14
Journal articleHepatic and extrahepatic insulin clearance in mice with double deletion of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors
Micaela Morettini, Agnese Piersanti, Laura Burattini, Giovanni Pacini, Christian Göbl, et al.
(2021) Biomedicines, 9
Journal articleGlucose-lowering action through targeting islet dysfunction in type 2 diabetes : Focus on dipeptidyl peptidase-4 inhibition
Bo Ahrén
(2021) Journal of Diabetes Investigation, 12 p.1128-1135
Journal article reviewThe Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice : Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice
Bo Ahrén, Yuichiro Yamada, Yutaka Seino
(2021) Frontiers in Endocrinology, 12
Journal articleGlucose effectiveness : Lessons from studies on insulin-independent glucose clearance in mice
Bo Ahrén, Giovanni Pacini
(2021) Journal of Diabetes Investigation, 12 p.675-685
Journal article reviewThe mediation by GLP-1 receptors of glucagon-induced insulin secretion revisited in GLP-1 receptor knockout mice
Bo Ahrén, Yuichiro Yamada, Yutaka Seino
(2021) Peptides, 135
Journal articleMathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test
Micaela Morettini, Laura Burattini, Christian Göbl, Giovanni Pacini, Bo Ahrén, et al.
(2021) Frontiers in Endocrinology, 12
Journal articleImpact of Incretin Hormone Receptors on Insulin-Independent Glucose Disposal in Model Experiments in Mice
Tina Ovlund, Giovanni Pacini, Bo Ahrén
(2021) Frontiers in Endocrinology, 12
Journal articleGlucagon-like peptide-1 and beta cell glucose sensitivity - a glucose ramp study in mice
Bo Ahrén
(2021) Peptides, 146
Journal articleConsequences on islet and incretin hormone responses to dinner by omission of lunch in healthy men
Ola Lindgren, Bo Ahrén
(2020) Endocrinology, Diabetes & Metabolism, 3
Journal articlePersistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes
Wathik Alsalim, Olga Göransson, Andrea Tura, Giovanni Pacini, Andrea Mari, et al.
(2020) Diabetes, Obesity and Metabolism, 22 p.590-598
Journal articleThe incretin effect in female mice with double deletion of GLP-1 and GIP receptors
Bo Ahrén, Yuichiro Yamada, Yutaka Seino
(2020) Journal of the Endocrine Society, 4
Journal articleIncretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes
Johan Farngren, Bo Ahrén
(2019) Metabolism: Clinical and Experimental, 99 p.25-31
Journal articleEffect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
Sheyda Sofizadeh, Henrik Imberg, Arndís F. Ólafsdóttir, Magnus Ekelund, Sofia Dahlqvist, et al.
(2019) Diabetes Therapy, 10 p.2115-2130
Journal articleDPP-4 inhibition and the path to clinical proof
Bo Ahrén
(2019) Frontiers in Endocrinology, 10
Journal articleGlucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice
Andrea Tura, Giovanni Pacini, Yuchiro Yamada, Yutaka Seino, Bo Ahrén
(2019) American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 316 p.27-37
Journal articleInsulin and incretin hormone responses to rapid versus slow ingestion of a standardized solid breakfast in healthy subjects.
Wathik Alsalim, Bo Ahrén
(2019) Endocrinology, Diabetes & Metabolism, 2 p.1-5
Journal articleEffect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5).
S. Ahmadi, Karin Filipsson, H Dimenäs, S Isaksson, H Imberg, et al.
(2019) Obesity Science Practice, 5 p.130-140
Journal articleGlucagon-like peptide-1 receptor agonists for type 2 diabetes : A rational drug development
Bo Ahrén
(2019) Journal of Diabetes Investigation, 10 p.196-201
Journal articleIslet adaptation in GIP receptor knockout mice
Bo Ahrén, Yuchiro Yamada, Yutaka Seino
(2019) Peptides
Journal article reviewReductioninglycatedhemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet : A randomized clinical trial
Daniela Jakubowicz, Zohar Landau, Shani Tsameret, Julio Wainstein, Itamar Raz, et al.
(2019) Diabetes Care, 42 p.2171-2180
Journal articleSemaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Bo Ahrén, Stephen L. Atkin, Guillaume Charpentier, Mark L. Warren, John P.H. Wilding, et al.
(2018) Diabetes, Obesity and Metabolism, 20 p.2210-2219
Journal articleEffects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes : A randomized, placebo-controlled study
Johan Farngren, Margaretha Persson, Bo Ahrén
(2018) Diabetes, Obesity and Metabolism, 20 p.1911-1920
Journal articleDifferent glucagon effects during DPP-4 inhibition versus SGLT-2 inhibition in metformin-treated type 2 diabetes patients
Wathik Alsalim, Margaretha Persson, Bo Ahrén
(2018) Diabetes, Obesity and Metabolism, 20 p.1652-1658
Journal articleIncreased insulin clearance in mice with double deletion of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors
Andrea Tura, Roberto Bizzotto, Yuchiro Yamada, Yutaka Seino, Giovanni Pacini, et al.
(2018) American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 314 p.639-646
Journal articleEffect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects
Wathik Alsalim, Olga Göransson, Richard D. Carr, Roberto Bizzotto, Andrea Tura, et al.
(2018) Diabetes, Obesity and Metabolism, 20 p.1080-1085
Journal articleDPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes
Marco Bugliani, Farooq Syed, Flavia M.M. Paula, Bilal A. Omar, Mara Suleiman, et al.
(2018) Molecular and Cellular Endocrinology, 473 p.186-193
Journal articleVariables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)
Sofia Dahlqvist, Elsa Ahlén, Karin Filipsson, Thomas Gustafsson, Irl B. Hirsch, et al.
(2018) BMJ Open Diabetes Research and Care, 6
Journal articleHigh-energy breakfast based on whey protein reduces body weight, postprandial glycemia and HbA1C in Type 2 diabetes
Daniela Jakubowicz, Julio Wainstein, Zohar Landau, Bo Ahren, Maayan Barnea, et al.
(2017) Journal of Nutritional Biochemistry, 49 p.1-7
Journal articleInfluences of breakfast on clock gene expression and postprandial glycemia in healthy individuals and individuals with diabetes : A randomized clinical trial
Daniela Jakubowicz, Julio Wainstein, Zohar Landau, Itamar Raz, Bo Ahren, et al.
(2017) Diabetes Care, 40 p.1573-1579
Journal articleAlain Ktorza, PhD
Bernard Thorens, Domenico Accili, Bo Ahrén, Christian Boitard, Susumu Seino, et al.
(2017) Diabetes, obesity & metabolism, 19 p.3-3
Journal article (comment)Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus : Long-term efficacy with or without rescue therapy
Philip D. Home, Bo Ahrén, Jane E.B. Reusch, Marc Rendell, Peter N. Weissman, et al.
(2017) Diabetes Research and Clinical Practice, 131 p.49-60
Journal articleEfficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2) : a 56-week, double-blind, phase 3a, randomised trial
Bo Ahrén, Luis Masmiquel, Harish Kumar, Mehmet Sargin, Julie Derving Karsbøl, et al.
(2017) The Lancet Diabetes and Endocrinology, 5 p.341-354
Journal articleOnce weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus : Results over 52 weeks
Lawrence A Leiter, Jorge Luiz Gross, Francis C C Chow, Diane Miller, Susan L Johnson, et al.
(2017) Journal of Diabetes and its Complications, 31 p.1283-1285
Journal articleGlucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice
Gina Song, Giovanni Pacini, Bo Ahrén, David Z. D'Argenio
(2017) Peptides, 88 p.74-79
Journal articleDiurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day : An analysis using continuous glucose monitoring
Richard M. Bergenstal, Ellie Strock, Roger Mazze, Margaret A. Powers, Arlene M. Monk, et al.
(2017) Diabetes/Metabolism Research and Reviews, 33
Journal articleAlbiglutide for the treatment of type 2 diabetes mellitus : An integrated safety analysis of the HARMONY phase 3 trials
Bo Ahrén, Molly C. Carr, Karen Murphy, Christopher Perkins, Marc Rendell, et al.
(2017) Diabetes Research and Clinical Practice, 126 p.230-239
Journal articleEffects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes : A randomized, open-label, 2-arm parallel comparative, exploratory trial
Daisuke Yabe, Takashi Eto, Masanari Shiramoto, Shin Irie, Kenta Murotani, et al.
(2017) Diabetes, Obesity and Metabolism, 19 p.442-447
Journal articleGlucagon-like peptide-1 and glucose-dependent insulinotropic peptide : effects alone and in combination on insulin secretion and glucose disappearance in mice
Giovanni Pacini, Bo Ahrén
(2017) Physiological Reports, 5
Journal articleThe vildagliptin experience - 25 years since the initiation of the novartis glucagon-like peptide-1 based therapy programme and 10 years since the first vildagliptin registration
James E Foley, Bo Ahrén
(2017) European Endocrinology, 13 p.56-61
Journal articleInsulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation
Kristine Færch, Dorte Vistisen, Giovanni Pacini, Signe S. Torekov, Nanna B. Johansen, et al.
(2016) Diabetes, 65 p.3473-3481
Journal articleEfficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes : The adjunct two randomized trial
Bo Ahren, Irl B. Hirsch, Thomas R. Pieber, Chantal Mathieu, Fernando Gomez-Peralta, et al.
(2016) Diabetes Care, 39 p.1693-1701
Journal articleEfficacy of lixisenatide in patients with type 2 diabetes : A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials
Daisuke Yabe, Anu Ambos, Bertrand Cariou, Lea Duvnjak, Marc Evans, et al.
(2016) Journal of Diabetes and its Complications, 30 p.1385-1392
Journal articlePostprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus : A Post Hoc Analysis
Bo Ahrén, Gagik Galstyan, Jean Francois Gautier, Francesco Giorgino, Fernando Gomez-Peralta, et al.
(2016) Diabetes Therapy, 7 p.583-590
Journal articleCART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion
Mia Abels, Matteo Riva, Hedvig Bennet, Emma Ahlqvist, Oleg Dyachok, et al.
(2016) Diabetologia, 59 p.1928-1937
Journal articleEvidence for neural contribution to islet effects of DPP-4 inhibition in mice
Linda Ahlkvist, Bilal Omar, Giovanni Pacini, Bo Ahrén
(2016) European Journal of Pharmacology, 780 p.46-52
Journal articleIncretin hormone receptors are required for normal beta cell development and function in female mice
Bilal Omar, Linda Ahlkvist, Yuchiro Yamada, Yutaka Seino, Bo Ahrén
(2016) Peptides, 79 p.58-65
Journal articleImproved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.
Bo Ahrén, James E Foley
(2016) Diabetologia
Journal articleMixed meal diminishes glucose excursion compared to glucose by several adaptive mechanisms in man.
Wathik Alsalim, Andrea Tura, Giovanni Pacini, Bilal Omar, Roberto Bizzotto, et al.
(2016) Diabetes, Obesity and Metabolism, 18 p.24-33
Journal articleEvidence for time dependent variation of glucagon secretion in mice.
Siri Malmgren, Bo Ahrén
(2016) Peptides, 76 p.102-107
Journal articleEfficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis.
Bernard Zinman, Bo Ahrén, Dietmar Neubacher, Sanjay Patel, Hans-Juergen Woerle, et al.
(2016) Canadian Journal of Diabetes, 40 p.50-57
Journal articleDecreased insulin secretion and glucose clearance in exocrine pancreas-insufficient pigs.
Liudmyla Lozinska, Björn Weström, Olena Prykhodko, Andreas Lindqvist, Nils Wierup, et al.
(2016) Experimental Physiology, 101 p.100-112
Journal articleEffect of the GLP-1 Receptor Agonist Lixisenatide on Counter-Regulatory Responses to Hypoglycemia in Subjects With Insulin-Treated Type 2 Diabetes.
Johan Farngren, Margaretha Persson, Bo Ahrén
(2016) Diabetes Care, 39 p.242-249
Journal articleEnhanced Insulin Sensitivity by Adipose Tissue Browning Alters Islet Morphology and Hormone Secretion in Response to Autonomic Nervous Activation in Female Mice.
Bilal Omar, Martina Kvist Reimer, Sven Enerback, Bo Ahrén
(2016) American Journal of Physiology: Endocrinology and Metabolism, 310 p.81-90
Journal articleDefective insulin secretion by chronic glucagon receptor activation in glucose intolerant mice.
Linda Ahlkvist, Bilal Omar, Anders Valeur, Keld Fosgerau, Bo Ahrén
(2016) Journal of Endocrinology, 228 p.171-178
Journal articleExtrapancreatic contribution to glucose regulation by dipeptidyl peptidase 4 inhibition
Bilal A. Omar, Bo Ahrén
(2016) Cardiovascular Endocrinology, 5 p.82-85
Journal article reviewEstimation of the Relative Contribution of Postprandial Glucose Exposure to Average Total Glucose Exposure in Subjects with Type 2 Diabetes
Bo Ahrén, James E. Foley
(2016) International Journal of Endocrinology, 2016
Journal articleFour-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin.
Andrea Tura, Johan Farngren, Anja Schweizer, James E Foley, Giovanni Pacini, et al.
(2015) International Journal of Endocrinology, 2015
Journal articleLiraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Marcus Lind, Irl B Hirsch, Jaakko Tuomilehto, Sofia Dahlqvist, Bo Ahrén, et al.
(2015) BMJ: British Medical Journal, 351 p.5364-5364
Journal articleDeciphering the hypoglycemic glucagon response: development of a graded hyperinsulinemic hypoglycemic clamp technique in female mice.
Siri Malmgren, Bo Ahrén
(2015) Endocrinology, 156 p.3866-3871
Journal articleThe Islet and Metabolism Keep Time
B. Thorens, D. Accili, Bo Ahrén, E. Cerasi, S. Seino, et al.
(2015) Diabetes, Obesity and Metabolism, 17 p.3-5
Journal article (comment)Glucagon and GLP-1 exhibit no synergistic enhancement of glucose-stimulated insulin secretion in mice.
Giovanni Pacini, Bo Ahrén
(2015) Peptides, 71 p.66-71
Journal articleDPP-4 inhibition contributes to the prevention of hypoglycaemia through a GIP-glucagon counterregulatory axis in mice.
Siri Malmgren, Bo Ahrén
(2015) Diabetologia, 58 p.1091-1099
Journal articleSurrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Are there not some surrogate indexes lost in this story? Reply to Bastard JP, Rabasa-Lhoret R, Laville M and Disse E [letter]
Julia Otten, Bo Ahrén, Tommy Olsson
(2015) Diabetologia, 58 p.416-417
Journal article (letter)High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: a randomised clinical trial
Daniela Jakubowicz, Julio Wainstein, Bo Ahrén, Yosefa Bar-Dayan, Zohar Landau, et al.
(2015) Diabetologia, 58 p.912-919
Journal articleFibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
Birgitte Andersen, Bilal Omar, Günaj Rakipovski, Kirsten Raun, Bo Ahrén
(2015) European Journal of Pharmacology, 764 p.189-194
Journal articleIncretin Effect after Oral Amino Acid Ingestion in Humans.
Ola Lindgren, Giovanni Pacini, Andrea Tura, Jens J Holst, Carolyn F Deacon, et al.
(2015) Journal of Clinical Endocrinology and Metabolism, 100 p.1172-1176
Journal articleGlucagon-early breakthroughs and recent discoveries.
Bo Ahrén
(2015) Peptides, 67 p.74-81
Journal article reviewIncretin and islet hormone responses to meals of increasing size in healthy subjects.
Wathik Alsalim, Bilal Omar, Giovanni Pacini, Roberto Bizzotto, Andrea Mari, et al.
(2015) Journal of Clinical Endocrinology and Metabolism, 100 p.561-568
Journal articleCreative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years?
Bo Ahrén
(2015) Diabetologia, 58 p.1740-1744
Journal article (comment)Physiological aspects of the combination of insulin and GLP-1 in the regulation of blood glucose control.
Bo Ahrén
(2015) Diabetes & Metabolism, 41 p.3-8
Journal articleHepato-Incretin Function of GLP-1: Novel Concept and Target in Type 1 Diabetes.
Bo Ahrén
(2015) Diabetes, 64 p.715-717
Journal article (comment)Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes: A Randomized Clinical Trial.
Daniela Jakubowicz, Julio Wainstein, Bo Ahrén, Zohar Landau, Yosefa Bar-Dayan, et al.
(2015) Diabetes Care, 38 p.1820-1826
Journal articleFour-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study.
Eu Jeong Ku, Kyong Yeon Jung, Yoon Ji Kim, Kyoung Min Kim, Jae Hoon Moon, et al.
(2015) PLoS ONE, 10
Journal articleHigher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?
Bo Ahrén, James Edward Foley, Sylvie Dejager, Mouna Akacha, Qing Shao, et al.
(2014) Diabetes therapy : research, treatment and education of diabetes and related disorders
Journal articleGlucagon clearance is regulated by nutritional state : Evidence from experimental studies in mice
Alyssa Zhou, Giovanni Pacini, Bo Ahrén, David Z. D'Argenio
(2014) Diabetologia, 57 p.801-808
Journal articleImpact of glucose dosing regimens on modeling of glucose tolerance and β-cell function by intravenous glucose tolerance test in diet-induced obese mice.
Bilal Omar, Giovanni Pacini, Bo Ahrén
(2014) Physiological Reports, 2
Journal articleConditional glucagon receptor overexpression has multi-faceted consequences for beta-cell function.
Bilal Omar, Maria Sörhede Winzell, Bo Ahrén
(2014) Metabolism, Clinical and Experimental, 63 p.1568-1576
Journal articleEfficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.
Bo Ahrén, Chantal Mathieu, Giovanni Bader, Anja Schweizer, James E Foley
(2014) Diabetologia, 57 p.1304-1307
Journal articleGLP-1 released to the mesenteric lymph duct in mice: Effects of glucose and fat.
Lena Ohlsson, Alison B Kohan, Patrick Tso, Bo Ahrén
(2014) Regulatory Peptides, 189 p.40-45
Journal articleGlucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes.
Johan Farngren, Margaretha Persson, A Schweizer, J E Foley, Bo Ahrén
(2014) Diabetes, Obesity and Metabolism, 16 p.812-818
Journal articleDipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets.
Liehua Liu, Bilal Omar, Piero Marchetti, Bo Ahrén
(2014) Biochemical and Biophysical Research Communications, 453 p.398-404
Journal articleThe neuro-incretin concept.
Bo Ahrén
(2014) Regulatory Peptides, 194 p.3-5
Journal article (comment)Fibroblast Growth Factor 21 (FGF21) and Glucagon Like-Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor Deficient Mice.
Bilal Omar, Birgitte Andersen, Jacob Hald, Kirsten Raun, Erica Nishimura, et al.
(2014) Diabetes, 63 p.101-110
Journal articleEqual improvement in glycaemia with lixisenatide given before breakfast or the main meal of the day.
Bo Ahrén, Natalia Vorokhobina, Elisabeth Souhami, Nacima Demil, Jenny Ye, et al.
(2014) Journal of Diabetes and its Complications, 28 p.735-741
Journal articleDipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes.
Bilal Omar, Liu Liehua, Yuchiro Yamada, Yutaka Seino, Piero Marchetti, et al.
(2014) Diabetologia, 57 p.1876-1883
Journal articleThe mind and the belly: a glance at how the nervous system directs metabolism
D. Accili, Bo Ahrén, C. Boitard, S. Seino, B. Thorens, et al.
(2014) Diabetes, Obesity and Metabolism, 16 p.1-3
Journal article (comment)Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial
Daniela Jakubowicz, Oren Froy, Bo Ahrén, Mona Boaz, Zohar Landau, et al.
(2014) Diabetologia, 57 p.1807-1811
Journal articleSurrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis
Julia Otten, Bo Ahrén, Tommy Olsson
(2014) Diabetologia, 57 p.1781-1788
Journal articlePronounced Reduction Of Postprandial Glucagon By Lixisenatide: A Meta-Analysis Of Randomized Clinical Trials.
Bo Ahrén, Jean-Francois Gautier, Rachele Berria, William Stager, Ronnie Aronson, et al.
(2014) Diabetes, Obesity and Metabolism, 16 p.861-868
Journal articleHARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin.
Bo Ahrén, Susan L Johnson, Murray Stewart, Deborah T Cirkel, Fred Yang, et al.
(2014) Diabetes Care, 37 p.2141-2148
Journal articlePleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 Inhibitors.
Bilal Omar, Bo Ahrén
(2014) Diabetes, 63 p.2196-2202
Journal articleAdvancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro.
Julio Rosenstock, Vivian A Fonseca, Jorge L Gross, Robert E Ratner, Bo Ahrén, et al.
(2014) Diabetes Care, 37 p.2317-2325
Journal articleInsulin plus incretin: A glucose-lowering strategy for type 2-diabetes.
Bo Ahrén
(2014) World Journal of Diabetes, 5 p.40-51
Journal article reviewUpregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion.
Linda Ahlkvist, K Brown, Bo Ahrén
(2013) Endocrine Connections, 2 p.69-78
Journal articleDipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
M. Monami, Bo Ahrén, I. Dicembrini, E. Mannucci
(2013) Diabetes, Obesity and Metabolism, 15 p.112-120
Journal articleIncretin dysfunction in type 2 diabetes: Clinical impact and future perspectives.
Bo Ahrén
(2013) Diabetes & Metabolism, 39 p.195-201
Journal article reviewSerum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
Per Johansson, Daniel Aberg, Jan-Ove Johansson, Niklas Mattsson, Oskar Hansson, et al.
(2013) Psychoneuroendocrinology, 38 p.1729-1737
Journal articleSitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function
M. Alba, Bo Ahrén, S. E. Inzucchi, Y. Guan, M. Mallick, et al.
(2013) Diabetes, Obesity and Metabolism, 15 p.1101-1110
Journal articleShifting the paradigm of islet inflammation-good guy or bad guy?
Bo Ahrén, D Accili, C Boitard, E Cerasi, B Thorens, et al.
(2013) Diabetes, Obesity and Metabolism, 15 p.4-9
Journal article (comment)Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.
Bo Ahrén
(2013) Vascular Health and Risk Management, 9 p.155-163
Journal articleGlucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.
Lena Ohlsson, Wathik Alsalim, Richard D Carr, Andrea Tura, Giovanni Pacini, et al.
(2013) Diabetes, Obesity and Metabolism, 15 p.531-537
Journal articleEfficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M).
Bo Ahrén, Aniceto Leguizamo Dimas, Patrick Miossec, Stéphane Saubadu, Ronnie Aronson
(2013) Diabetes Care, 36 p.2543-2550
Journal articleMethods and Models for Metabolic Assessment in Mice
G. Pacini, Bilal Omar, Bo Ahrén
(2013) Journal of Diabetes Research
Journal articleEnhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.
Bilal Omar, Jenny Vikman, Maria Sörhede Winzell, Ulrikke Voss, Eva Ekblad, et al.
(2013) Diabetologia, 56 p.1752-1760
Journal articleSerum but not Cerebrospinal Fluid levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3) are Increased in Alzheimer ́s Disease
Per Johansson, D. Åberg, J-O Johansson, N. Mattsson, Oskar Hansson, et al.
(2013)
PosterIslet nerves in focus-defining their neurobiological and clinical role.
Bo Ahrén
(2012) Diabetologia
Journal articleVarning för okritisk användning av överviktskirurgi vid typ 2-diabetes.
Carl-David Agardh, Bo Ahrén, Ragnar Hanås, Stefan Jansson, Ulf Smith, et al.
(2012) Läkartidningen, 109 p.1208-1209
Journal articleDPP-4 inhibition and islet function
Bo Ahrén
(2012) Journal of Diabetes Investigation, 3 p.3-10
Journal article reviewThe hyperstimulated beta-cell: prelude to diabetes?
Christian Boitard, Domenico Accili, Bo Ahrén, Erol Cerasi, Susumu Seino, et al.
(2012) Diabetes, Obesity and Metabolism, 14
Journal article (comment)Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
C F Deacon, E Mannucci, Bo Ahrén
(2012) Diabetes, Obesity and Metabolism, 14 p.762-767
Journal articleSynergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice.
Linda Ahlkvist, Jenny Vikman, G Pacini, Bo Ahrén
(2012) Regulatory Peptides, 178 p.29-35
Journal articlePlasma lipid fatty acid composition, desaturase activities and insulin sensitivity in Amerindian women
B. Vessby, Bo Ahrén, E. Warensjo, Folke Lindgärde
(2012) Nutrition Metabolism and Cardiovascular Diseases, 22 p.176-181
Journal articleUsing albumin to improve the therapeutic properties of diabetes treatments.
Bo Ahrén, B Burke
(2012) Diabetes, Obesity and Metabolism, 14 p.121-129
Journal articleSwitching From High-Fat to Low-Fat Diet Normalizes Glucose Metabolism and Improves Glucose-Stimulated Insulin Secretion and Insulin Sensitivity But Not Body Weight in C57BL/6J Mice.
Carl-David Agardh, Bo Ahrén
(2012) Pancreas, 41 p.253-257
Journal articleIncretin hormones and the up-regulation of insulin secretion in insulin resistance.
Bo Ahrén
(2012) The Journal of clinical endocrinology and metabolism, 97 p.1173-1175
Journal articleVildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
Johan Farngren, Margaretha Persson, Anja Schweizer, James E Foley, Bo Ahrén
(2012) The Journal of clinical endocrinology and metabolism, 97 p.3799-3806
Journal articleDifferential Development of Glucose Intolerance and Pancreatic Islet Adaptation in Multiple Diet Induced Obesity Models
Bilal Omar, Giovanni Pacini, Bo Ahrén
(2012) Nutrients, 4 p.1367-1381
Journal articleThe dynamic incretin adaptation and type 2 diabetes.
Bo Ahrén
(2011) Journal of Clinical Endocrinology and Metabolism, 96 p.620-622
Journal articleEffects of increasing doses of glucagon-like peptide-1 on insulin-releasing phases during intravenous glucose administration in mice
Hui Min Chan, Ritesh Jain, Bo Ahrén, Giovanni Pacini, David Z. D'Argenio
(2011) American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 300 p.1126-1133
Journal articleEditorial: Long in the shade, glucagon re-occupies centre court
J. -C. Henquin, D. Accili, Bo Ahrén, C. Boitard, S. Seino, et al.
(2011) Diabetes, Obesity and Metabolism, 13
Journal article (comment)Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?
Bo Ahrén
(2011) Current Diabetes Reports, 11 p.83-90
Journal articleClinical evidence and mechanistic basis for vildagliptin's action when added to metformin.
Bo Ahrén, J E Foley, E Bosi
(2011) Diabetes, Obesity and Metabolism, 13 p.193-203
Journal articleThe future of incretin-based therapy: novel avenues-novel targets.
Bo Ahrén
(2011) Diabetes, Obesity and Metabolism, 13 Suppl 1 p.158-166
Journal articleChronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice.
Maria Sörhede Winzell, Matthew Coghlan, Brendan Leighton, Georgia Frangioudakis, David M Smith, et al.
(2011) European Journal of Pharmacology, 663 p.80-86
Journal articleMechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
Bo Ahrén, A. Schweizer, S. Dejager, E. B. Villhauer, B. E. Dunning, et al.
(2011) Diabetes, Obesity and Metabolism, 13 p.775-783
Journal article reviewPositive correlation between tumor necrosis factor (TNF)-alpha and cardiorespiratory fitness after six-months of regular aerobic exercise in Peruvian Amerindian women
Folke Lindgärde, Anders Gottsäter, Bo Ahrén
(2011) Revista Médica de Chile, 139 p.998-1005
Journal articleGastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase 4 activity in obese patients with type 2 diabetes.
M Alam, B J Van der Schueren, Bo Ahrén, G C Wang, N J Swerdlow, et al.
(2011) Diabetes, Obesity and Metabolism, 13 p.378-381
Journal articleGLP-1 for type 2 diabetes
Bo Ahrén
(2011) Experimental Cell Research, 317 p.1239-1245
Journal article reviewDissociated incretin hormone response to protein versus fat ingestion in obese subjects.
Ola Lindgren, R Carr, J J Holst, C Deacon, Bo Ahrén
(2011) Diabetes, Obesity and Metabolism, 13 p.863-865
Journal articleReply to the letter by P. Guillausseau Regarding "Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate Is Not Yet Closed"
Bo Ahrén
(2011) Current Diabetes Reports, 11 p.463-463
Journal articleIncretin Hormone and Insulin Responses to Oral Versus Intravenous Lipid Administration in Humans.
Ola Lindgren, Richard D Carr, Carolyn F Deacon, Jens J Holst, Giovanni Pacini, et al.
(2011) The Journal of clinical endocrinology and metabolism, 96 p.2519-2524
Journal articleIncreased IL-1 beta reactivity upon a glucose challenge in patients with deliberate self-harm
Sofie Westling, Bo Ahrén, Lil Träskman Bendz, Lena Brundin
(2011) Acta Psychiatrica Scandinavica, 124 p.301-306
Journal articleOverexpression of Foxf2 in adipose tissue is associated with lower levels of IRS1 and decreased glucose uptake in vivo
Rickard Westergren, Daniel Nilsson, Mikael Heglind, Zahra Arani, Mats Grande, et al.
(2010) American Journal of Physiology: Endocrinology and Metabolism, 298 p.548-554
Journal articleDissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice
Giovanni Pacini, Karl Thomaseth, Bo Ahrén
(2010) Metabolism, Clinical and Experimental, 59 p.988-992
Journal articleChanges in Prandial Glucagon Levels after 2-year Treatment with Vildagliptin or Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy.
Bo Ahrén, James E Foley, E Ferrannini, David R Matthews, Bernard Zinman, et al.
(2010) Diabetes Care, 33 p.730-732
Journal articleDisassociated relation between plasma tumor necrosis factor-alpha, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight variation and impaired glucose tolerance
Folke Lindgärde, Anders Gottsäter, Bo Ahrén
(2010) Diabetology and Metabolic Syndrome, 2
Journal articleCerebrospinal fluid insulin during non-neurological surgery
Sara Bromander, Rolf Anckarsater, Bo Ahrén, Marianne Kristiansson, Kaj Blennow, et al.
(2010) Journal of Neural Transmission, 117 p.1167-1170
Journal articleGlucagon normalises disposition index by increasing acute insulin response to intravenous glucose: comparison with incretins
G. Pacini, Bo Ahrén
(2010) Diabetologia, 53 p.694-694
Conference paper: abstractDegradation of GIP but not of GLP-1 is reduced after protein ingestion in obese subjects
Ola Lindgren, Jenny Vikman, C. F. Deacon, R. D. Carr, J. J. Holst, et al.
(2010) Diabetologia, 53 p.646-646
Conference paper: abstractImproved insulin sensitivity and islet function after PPARdelta activation in diabetic db/db mice.
Maria Sörhede Winzell, Erik Max Wulff, Grith Skytte Olsen, Per Sauerberg, Carsten F Gotfredsen, et al.
(2010) European Journal of Pharmacology, 626 p.297-305
Journal articleVildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
D. R. Matthews, S. Dejager, Bo Ahrén, V. Fonseca, E. Ferrannini, et al.
(2010) Diabetes, Obesity and Metabolism, 12 p.780-789
Journal articleCART is upregulated in islets of type 2 diabetic patients, stimulates insulin secretion, inhibits glucagon secretion and protects against beta cell death
Ramasri Sathanoori, Ulrikke Voss, Matteo Riva, Maria Sörhede Winzell, Bo Ahrén, et al.
(2010) Diabetologia, 53 p.95-95
Conference paper: abstractIncreased beta-cell volume in mice fed a high-fat diet A dynamic study over 12 months
Jonatan Ahren, Bo Ahrén, Nils Wierup
(2010) Islets, 2 p.353-356
Journal articleWhat ails the beta-cell?
D. Accili, Bo Ahrén, C. Boitard, E. Cerasi, J. -C. Henquin, et al.
(2010) Diabetes, Obesity and Metabolism, 12 p.1-3
Journal article (comment)Changes in cerebrospinal fluid insulin during non-neurological surgery
S. Bromander, R. Anckarsater, Bo Ahrén, M. Kristiansson, K. Blennow, et al.
(2010) European Neuropsychopharmacology, 20 p.328-329
Conference paper: abstractThe incretin effect is apparent after lipid challenge in healthy humans
Bo Ahrén, Ola Lindgren, Jenny Vikman, C. F. Deacon, J. J. Holst, et al.
(2010) Diabetologia, 53 p.648-648
Conference paper: abstractPituitary adenylate cyclase-activating polypeptide (PACAP) and islet function
Bo Ahrén
(2010) Regulatory Peptides, 164 p.23-23
Conference paper: abstractCocaine- and amphetamine-regulated transcript (CART) is upregulated in islets of type-2 diabetic patients to stimulate insulin secretion, inhibit glucagon secretion and protect against beta cell death
Ramasri Sathanoori, Ulrikke Voss, Matteo Riva, Maria Sörhede Winzell, Bo Ahrén, et al.
(2010) Regulatory Peptides, 164 p.45-45
Conference paper: abstractIncreased β-cell volume in mice fed a high-fat diet: A dynamic study over 12 months.
Jonatan Ahrén, Bo Ahrén, Nils Wierup
(2010) Islets, 2 p.12-15
Journal articleIncretin hormone secretion over the day.
Bo Ahrén, Richard D Carr, Carolyn F Deacon
(2010) Vitamines and Hormones, 84 p.203-220
Journal articleEget ansvar i vården?
(2010)
BookSecretion and Dipeptidyl Peptidase-4-Mediated Metabolism of Incretin Hormones after a Mixed Meal or Glucose Ingestion in Obese Compared to Lean, Nondiabetic Men.
Richard D Carr, Marianne O Larsen, Katarina Jelic, Ola Lindgren, Jenny Vikman, et al.
(2010) The Journal of clinical endocrinology and metabolism, 95 p.872-878
Journal articleA paleolithic diet is more satiating per calorie than a mediterranean-like diet in individuals with ischemic heart disease.
Tommy Jönsson, Yvonne Granfeldt, Charlotte Erlanson-Albertsson, Bo Ahrén, Staffan Lindeberg
(2010) Nutrition & Metabolism, 7 p.85-99
Journal articleStudy on administration of 1,5-anhydro-D-fructose in C57BL/6J mice challenged with high-fat diet
Jie Mei, Shukun Yu, Bo Ahrén
(2010) BMC Endocrine Disorders, 10
Journal articleBeneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
Tommy Jönsson, Yvonne Granfeldt, Bo Ahrén, Ulla-Carin Branell, Gunvor Pålsson, et al.
(2009) Cardiovascular Diabetology, 8
Journal articlebeta- and alpha-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance Outcome of a 12-Year Prospective Study in Postmenopausal Caucasian Women
Bo Ahrén
(2009) Diabetes, 58 p.726-731
Journal articleReappraisal of the intravenous glucose tolerance index for a simple assessment of insulin sensitivity in mice
Giovanni Pacini, Maria Ahren, Bo Ahrén
(2009) American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 296 p.1316-1324
Journal articleModulation of Fasted and Postprandial Plasma Lipids in Healthy Volunteers by a Dietary Mixture of Omega-3 Fatty Acids and Conjugated Linoleic Acid
Fotini Tsofliou, Claire L. Fyfe, Ian Matheson, Diane M. Jackson, Graham W. Horgan, et al.
(2009) Journal of Food Lipids, 16 p.499-513
Journal articleClinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin - diabetes control and potential adverse events
Bo Ahrén
(2009) Best Practice and Research in Clinical Endocrinology and Metabolism, 23 p.487-498
Journal articleVildagliptin improves glucose sensitivity of cells in patients with type 2 diabetes: glucagon response to hypoglycemia
J. F. Gautier, S. Dejager, J. Foley, S. Halimi, Bo Ahrén
(2009) Diabetes & Metabolism, 35 p.8-8
Conference paper: abstractGIP and GLP-1 normalize glucose tolerance by normalizing islet adaptation to insulin resistance without increasing glucose effectiveness in high-fat fed mice
G. Pacini, Bo Ahrén
(2009) Diabetologia, 52 p.197-197
Conference paper: abstractChanges in prandial glucagon levels after 2 years treatment with vildagliptin or glimepiride
Bo Ahrén, J. Foley, E. Ferrannini, D. Matthews, B. Zinman, et al.
(2009) Diabetologia, 52 p.798-798
Conference paper: abstractbeta-Cell research - A decade of rapid growth
Bo Ahrén, Domenico Accili, Christian Boitard, Suad Efendic, Jean-Claude Henquin, et al.
(2009) Diabetes, Obesity and Metabolism, 11
Journal articleArterial Gastroduodenal Infusion of Cholecystokinin-33 Stimulates the Exocrine Pancreatic Enzyme Release Via an Enteropancreatic Reflex, Without Affecting the Endocrine Insulin Secretion in Pigs.
Sofia Rengman, Björn Weström, Bo Ahrén, Stefan Pierzynowski
(2009) Pancreas, 38 p.213-218
Journal articleChanges in cerebrospinal fluid insulin during non-neurological surgery
S. Bromander, R. Anckarsater, Bo Ahrén, M. Kristiansson, Lil Träskman Bendz, et al.
(2009) Diabetologia, 52 p.677-677
Conference paper: abstractAltered glucose tolerance in women with deliberate self-harm.
Sofie Westling, Bo Ahrén, Charlotta Sunnqvist, Lil Träskman Bendz
(2009) Psychoneuroendocrinology, 34 p.878-883
Journal articleInhibitory effect of kisspeptins on insulin secretion from isolated mouse islets.
Jenny Vikman, Bo Ahrén
(2009) Diabetes, Obesity and Metabolism, 11 Suppl 4 p.197-201
Journal articleEffects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men.
Bo Ahrén, A Mari, C L Fyfe, F Tsofliou, A A Sneddon, et al.
(2009) European Journal of Clinical Nutrition, Sep 3 p.778-786
Journal articleVildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes.
Bo Ahrén, Anja Schweizer, Sylvie Dejager, Beth E Dunning, Peter Nilsson, et al.
(2009) Journal of Clinical Endocrinology and Metabolism, 94 p.1236-1243
Journal articleDifferential reduction in incretin hormone response to different macronutrients in obese vs lean healthy subjects
Ola Lindgren, Jenny Vikman, C. F. Deacon, Bo Ahrén
(2009) Diabetologia, 52 p.568-568
Conference paper: abstractIslet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.
Bo Ahrén
(2009) Nature Reviews. Drug Discovery, 8 p.369-385
Journal article reviewFifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
E. Ferrannini, V. Fonseca, B. Zinman, D. Matthews, Bo Ahrén, et al.
(2009) Diabetes, Obesity and Metabolism, 11 p.157-166
Journal articleDissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery
M. Guldstrand, Bo Ahrén, E. Naslund, J. J. Holst, U. Adamson
(2009) Diabetes, Obesity and Metabolism, 11 p.1027-1033
Journal articleDifferential Islet and Incretin Hormone Responses in Morning vs. Afternoon after Standardized Meal in Healthy Men.
Ola Lindgren, Andrea Mari, Carolyn F Deacon, Richard D Carr, Maria Sörhede Winzell, et al.
(2009) The Journal of clinical endocrinology and metabolism, 94 p.2887-2892
Journal articleIncretin and islet hormonal responses to fat and protein ingestion in healthy men
Richard D. Carr, Marianne O. Larsen, Maria Sörhede Winzell, Katarina Jelic, Ola Lindgren, et al.
(2008) American Journal of Physiology: Endocrinology and Metabolism, 295 p.779-784
Journal articleRole of pituitary adenylate cyclase-activating polypeptide in the pancreatic endocrine system.
Bo Ahrén
(2008) Annals of the New York Academy of Sciences, 1144 p.28-35
Journal articleEffect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin
Alan A Sneddon, Fotini Tsofliou, Claire L Fyfe, Ian Matheson, Diane M Jackson, et al.
(2008) Obesity, 16 p.1019-1024
Journal articleReconstructing the pancreas: Restoration of normoglycemia, exocrine function, and islet innervation by islet transplantation to the pancreas
J. Stagner, Bo Ahrén, Frank Sundler, K. White
(2008) Transplantation Proceedings, 40 p.452-454
Journal articleHuman Islet Amyloid Polypeptide Transgenic Mice: In Vivo and Ex Vivo Models for the Role of hIAPP in Type 2 Diabetes Mellitus
J. W. M. Hoppener, H. M. Jacobs, N. Wierup, G. Sotthewes, M. Sprong, et al.
(2008) Experimental Diabetes Research
Journal articleSex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis
Maria A. Eriksson, Eva Rask, Owe Johnson, Kjell Carlstrom, Bo Ahrén, et al.
(2008) Blood Coagulation and Fibrinolysis, 19 p.625-632
Journal articleBody fat related to daily physical activity and insulin concentrations in non-diabetic children.
Magnus Dencker, Ola Thorsson, Magnus Karlsson, Christian Lindén, Stig Eiberg, et al.
(2008) Clinical Physiology and Functional Imaging, 28 p.211-215
Journal articleThe augmenting effect on insulin secretion by oral versus intravenous glucose is exaggerated by high-fat diet in mice.
Bo Ahrén, Maria Sörhede Winzell, Giovanni Pacini
(2008) Journal of Endocrinology, 197 p.181-187
Journal articleNovel combination treatment of type 2 diabetes DPP-4 inhibition + metformin.
Bo Ahrén
(2008) Vascular Health and Risk Management, 4 p.383-394
Journal articleEvidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans.
Bo Ahrén
(2008) Diabetologia, 51 p.1018-1024
Journal articleDisturbed alpha-cell function in mice with beta-cell specific overexpression of human islet amyloid polypeptide.
Bo Ahrén, Maria Sörhede Winzell
(2008) Experimental Diabetes Research, 2008
Journal articleEmerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes.
Bo Ahrén
(2008) Expert Opinion on Emerging Drugs, 13 p.593-607
Journal articleDurable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
Maria Sörhede Winzell, Bo Ahrén
(2008) Journal of Molecular Endocrinology, 40 p.93-100
Journal articleClinical measures of islet function: usefulness to characterize defects in diabetes.
Bo Ahrén, Richard E Pratley, Mazin Soubt, Beth E Dunning, James E Foley
(2008) Current Diabetes Reviews, 4 p.129-145
Journal articleThe islet enhancer vildagliptin: mechanisms of improved glucose metabolism.
Bo Ahrén, J E Foley
(2008) International journal of clinical practice. Supplement, 62 p.8-14
Journal articleVildagliptin improves alpha cell glucose sensing in patients with type 2 diabetes
Bo Ahrén, A. Schweizer, S. Dejager, B. E. Dunning, Margaretha Persson, et al.
(2008) Diabetologia, 51 p.36-37
Conference paper: abstractDiurnal variation in the incretin response to a meal challenge in humans
Ola Lindgren, Maria Sörhede Winzell, C. Deacon, Bo Ahrén
(2008) Diabetologia, 51 p.247-247
Conference paper: abstractTemporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice.
Maria Sörhede Winzell, Caroline Magnusson, Bo Ahrén
(2007) Metabolism, Clinical and Experimental, 56 p.122-128
Journal articleDPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
Bo Ahrén, Maria Sorhede Winzell, Nils Wierup, Frank Sundler, Bryan Burkey, et al.
(2007) Regulatory Peptides, 143 p.97-103
Journal articleGlucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.
Maria Sörhede Winzell, C Brand, Nils Wierup, U Sidelmann, Frank Sundler, et al.
(2007) Diabetologia, 50 p.1453-1462
Journal articleThe impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits.
Astrid H Petersen, Torben Laursen, Bo Ahrén, Thomas R Pieber, Per Clauson, et al.
(2007) European Journal of Pharmaceutical Sciences, 30 p.351-357
Journal articleInsulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects.
Bo Ahrén
(2007) Diabetes Care, 30 p.644-648
Journal articleG-protein-coupled receptors and islet function-Implications for treatment of type 2 diabetes.
Maria Sörhede Winzell, Bo Ahrén
(2007) Pharmacology and Therapeutics, 116 p.437-448
Journal articleImproved meal-related insulin processing contributes to the enhancement of B-Cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes
Bo Ahrén, G. Pacini, A. Tura, J. E. Foley, A. Schweizer
(2007) Hormone and Metabolic Research, 39 p.826-829
Journal articleGPR40 is expressed in glucagon producing cells and affects glucagon secretion.
Erik Flodgren, Björn Olde, Sandra Meidute, Maria Sörhede Winzell, Bo Ahrén, et al.
(2007) Biochemical and Biophysical Research Communications, 354 p.240-245
Journal articleGender-specific links between hepatic 11 beta reduction of cortisone and adipokines
Cecilia Mattsson, Eva Rask, Kjell Carlstroem, Jonas Andersson, Mats Eliasson, et al.
(2007) Obesity Research, 15 p.887-894
Journal articleGlucagon-like peptide-1 accelerates the onset of insulin action on glucose disappearance in mice
K. Thomaseth, A. Pavan, G. Pacini, Bo Ahrén
(2007) American Journal of Physiology: Endocrinology and Metabolism, 292 p.1808-1814
Journal articleDPP-4 Inhibitors -- Clinical Data and Clinical Implications.
Bo Ahrén
(2007) Diabetes Care, 30 p.1344-1350
Journal article reviewGLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors.
Bo Ahrén
(2007) Current Diabetes Reports, 7 p.340-347
Journal articleOmega-3 fatty acids and other PUFAs and weight control
Maria Sörhede Winzell, Bo Ahrén
(2007) Novel food ingredients for weight control
Book chapterTvå genombrott i behandling av typ 2-diabetes. Både receptoragonist och enzymhämmare har nu nått kliniken.
Bo Ahrén
(2007) Läkartidningen, 104 p.3763-3764
Journal articleDPP-4 inhibitors.
Bo Ahrén
(2007) Baillière's Best Practice & Research in Clinical Endocrinology & Metabolism, 21 p.517-533
Journal articleImproved metabolic risk markers following two 6-month physical activity programs among socioeconomic marginalized women of native American ancestry in Lima, Peru
Folke Lindgärde, Bo Ahrén
(2007) Diabetes Care, 30 p.2230-2232
Journal articleRole of VIP and PACAP in islet function
Maria Sörhede Winzell, Bo Ahrén
(2007) Peptides, 28 p.1805-1813
Journal articleCapsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes
Dorte X. Gram, Bo Ahrén, Istvan Nagy, Uffe B. Olsen, Christian L. Brand, et al.
(2007) European Journal of Neuroscience, 25 p.213-223
Journal articleA Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease.
Staffan Lindeberg, Tommy Jönsson, Yvonne Granfeldt, E Borgstrand, J Soffman, et al.
(2007) Diabetologia, 50 p.1795-1807
Journal articleA Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs.
Tommy Jönsson, Bo Ahrén, Giovanni Pacini, Frank Sundler, Nils Wierup, et al.
(2006) Nutrition & Metabolism, 3
Journal articleVildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties.
Bo Ahrén
(2006) Expert Opinion on Investigational Drugs, 15 p.431-442
Journal articleThe insulin response to gastric glucose is reduced in PAC1 and GRP receptor gene deleted mice.
Bo Ahrén
(2006) Nutrition Metabolism and Cardiovascular Diseases, 16 Suppl 1 p.17-21
Journal articleEvidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver
G Bryzgalova, H Gao, Bo Ahrén, JR Zierath, D Galuska, et al.
(2006) Diabetologia, 49 p.588-597
Journal articleEarly and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B.
Helena Jones, Linda Härndahl, Nils Wierup, Emilia Zmuda-Trzebiatowska, Fredrik Svennelid, et al.
(2006) Journal of Endocrinology, 189 p.629-641
Journal articlePostprandial interstitial insulin concentrations in type 2 diabetes relatives
M Sandqvist, EH Johanson, Bo Ahrén, M Axelsen, M Schmelz, et al.
(2006) European Journal of Clinical Investigation, 36 p.383-388
Journal articleContributions from the first SICOD meeting (Stockholm, October 2004)
Bo Ahrén, G Pacini
(2006) Nutrition Metabolism and Cardiovascular Diseases, 16 p.1-2
Journal article (comment)Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice.
Maria Sörhede Winzell, Giovanni Pacini, Bo Ahrén
(2006) American Journal of Physiology: Endocrinology and Metabolism, 290 p.347-354
Journal articleDown-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells.
Ning Xu, Bo Ahrén, Jingting Jiang, Peter Nilsson-Ehle
(2006) Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1761 p.256-260
Journal articleIn vivo and in vitro glucose-induced biphasic insulin secretion in the mouse - Pattern and role of cytoplasmic Ca2+ and amplification signals in beta-cells
JC Henquin, M Nenquin, P Stiernet, Bo Ahrén
(2006) Diabetes, 55 p.441-451
Journal articleSuppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin.
Ning Xu, Peter Nilsson-Ehle, Bo Ahrén
(2006) Biochemical and Biophysical Research Communications, 342 p.1174-1177
Journal articleGlucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function
Heidi Sorensen, Maria Sörhede Winzell, Christian L. Brand, Keld Fosgerau, Richard W. Gelling, et al.
(2006) Diabetes, 55 p.3463-3469
Journal articleNeuropeptides and the regulation of islet function.
Bo Ahrén, Nils Wierup, Frank Sundler
(2006) Diabetes, 55 p.98-107
Journal articleMature-onset obesity in interleukin-1 receptor I knockout mice
MC Garcia, I Wernstedt, A Berndtsson, M Enge, M Bell, et al.
(2006) Diabetes, 55 p.1205-1213
Journal articleImprovement in cardiac systolic function and reduced prevalence of metabolic syndrome after 2 years of GH treatment in GH deficient adult survivors of childhood acute lymphoblastic leukaemia.
Cecilia Follin, Ulf Thilén, Bo Ahrén, Eva Marie Erfurth
(2006) Journal of Clinical Endocrinology and Metabolism, 91 p.1872-1875
Journal articleLeptin is closely related to body fat in prepubertal children aged 8-11 years.
Magnus Dencker, Ola Thorsson, Magnus K Karlsson, Christian Lindén, Per Wollmer, et al.
(2006) Acta Pædiatrica, 95 p.975-979
Journal articleSerum cholesteryl fatty acid composition and plasma glucose concentrations in Amerindian women.
Folke Lindgärde, Bengt Vessby, Bo Ahrén
(2006) American Journal of Clinical Nutrition, 84 p.1009-1013
Journal article{beta}-Cell Lipases and Insulin Secretion.
Malin Fex, Stephanie Lucas, Maria Sörhede Winzell, Bo Ahrén, Cecilia Holm, et al.
(2006) Diabetes, 55 p.24-31
Journal articleA Novel Approach to Assess Insulin Sensitivity Reveals No Increased Insulin Sensitivity in Mice with a Dominant-Negative Mutant Hepatocyte Nuclear Factor-1{alpha}
Bo Ahrén, G Pacini
(2006) American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 291 p.131-137
Journal articleKlinisk forskning måste baseras på team av både kliniker och forskare
Bo Ahrén
(2006) Läkartidningen, 103 p.2575-2575
Journal article (letter)Adrenal incidentaloma - follow-up results from a Swedish prospective study
B Bulow, S Jansson, C Juhlin, L Steen, M Thoren, et al.
(2006) European Journal of Endocrinology, 154 p.419-423
Journal articleBinding and the effect of the red kidney bean lectin, phytohaemagglutinin, in the gastrointestinal tract of suckling rats
Ann Linderoth, Olena Prykhodko, Bo Ahrén, Frida Fåk, Stefan Pierzynowski, et al.
(2006) British Journal of Nutrition, 95 p.105-115
Journal articleGlucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice.
Thomas Gunnarsson, Maria Sörhede Winzell, Carolyn F Deacon, Marianne O Larsen, Katarina Jelic, et al.
(2006) Endocrinology, 147 p.3173-3180
Journal articleGlucagon secretion in relation to insulin sensitivity in healthy subjects.
Bo Ahrén
(2006) Diabetologia, 49 p.117-122
Journal articleGlucose-stimulated insulin secretion correlates with beta-cell lipolysis.
Maria Sörhede Winzell, Kristoffer Ström, Cecilia Holm, Bo Ahrén
(2006) Nutrition Metabolism and Cardiovascular Diseases, 16 p.11-16
Journal articleInhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice
Bo Ahrén, TE Hughes
(2005) Endocrinology, 146 p.2055-2059
Journal articleAlpha cell function in health and disease: influence of glucagon-like peptide-1
B E Dunning, J E Foley, Bo Ahrén
(2005) Diabetologia, 48 p.1700-1713
Journal article reviewBeta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice.
Bo Ahrén, Maria Sörhede Winzell, Bryan Burkey, Thomas E Hughes
(2005) European Journal of Pharmacology, 521 p.164-168
Journal articleLow adipocyte IRS-1 protein expression is associated with an increased arterial stiffness in non-diabetic males
M Sandqvist, G Nyberg, A Hammarstedt, N Klintland, S Gogg, et al.
(2005) Atherosclerosis, 180 p.119-125
Journal articleWhat mediates the benefits associated with dipeptidyl peptidase-IV inhibition?
Bo Ahrén
(2005) Diabetologia, 48 p.605-607
Journal article (letter)Three-Day Enteral Exposure to a Red Kidney Bean Lectin Preparation Enhances the Pancreatic Response to CCK Stimulation in Suckling Pigs.
L. Evilevitch, Stefan Pierzynowski, Ann Linderoth, Bo Ahrén, Ch. Erlanson-Albertsson, et al.
(2005) Biology of the Neonate, 87 p.20-25
Journal articleCART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight
Nils Wierup, W.G. Richards, A.W. Bannon, M.J. Kuhar, Bo Ahrén, et al.
(2005) Regulatory Peptides, 129 p.203-211
Journal articleSensory nerve inactivation by resiniferatoxin improves insulin sensitivity in male obese Zucker rats
S G Moesgaard, C L Brand, J Sturis, Bo Ahrén, M Wilken, et al.
(2005) American Journal of Physiology: Endocrinology and Metabolism, 288 p.1137-1145
Journal articleGrowth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia
M Bohlooly, B Olsson, CEG Bruder, D Linden, K Sjogren, et al.
(2005) Diabetes, 54 p.51-62
Journal articleA 90-day toxicological evaluation of 1,5-anhydro-d-fructose in Sprague-Dawley rats.
Jie Mei, Shukun Yu, Bo Ahrén
(2005) Drug and Chemical Toxicology, 28 p.263-272
Journal articleImproved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year.
Bo Ahrén, Giovanni Pacini, James E Foley, Anja Schweizer
(2005) Diabetes Care, 28 p.1936-1940
Journal articleAssessment of insulin secretion in relation to insulin resistance.
Andrea Mari, Bo Ahrén, Giovanni Pacini
(2005) Current Opinion in Clinical Nutrition and Metabolic Care, 8 p.529-533
Journal articleAgrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance?
Tommy Jönsson, Stefan Olsson, Bo Ahrén, Thorkild C Bog-Hansen, Anita Dole, et al.
(2005) BMC Endocrine Disorders, 5
Journal articleType 2 Diabetes, Insulin Secretion and beta-Cell Mass.
Bo Ahrén
(2005) Current Molecular Medicine, 5 p.275-286
Journal article reviewNy strategi vid typ 2-diabetes prövas i kliniska studier. Glukagonlik peptid 1 (GLP-1) påverkar sjukdomens grundorsaker
Bo Ahrén
(2005) Läkartidningen, 102 p.9-545
Journal articleIslet adaptation to insulin resistance: mechanisms and implications for intervention.
Bo Ahrén, G Pacini
(2005) Diabetes, Obesity and Metabolism, 7 p.2-8
Journal article reviewThe apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice.
Maria Sörhede Winzell, Caroline Magnusson, Bo Ahrén
(2005) Regulatory Peptides, 131 p.12-17
Journal articleReduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice.
Bo Ahrén, K Thomaseth, G Pacini
(2005) Diabetologia, 48 p.2140-2146
Journal articleGastric Carcinoids: Biologic Behavior and Prognosis After Differentiated Treatment in Relation to Type.
Kurt Borch, Bo Ahrén, Håkan Ahlman, Sture Falkmer, Göran Granérus, et al.
(2005) Annals of Surgery, 242 p.64-73
Journal articleComparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test
A Mari, G Pacini, A R Brazzale, Bo Ahrén
(2005) Diabetologia, 48 p.748-751
Journal articleBovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet
B Olsson, M Bohlooly-Y, SM Fitzgerald, F Frick, A Ljungberg, et al.
(2005) Endocrinology, 146 p.920-930
Journal articleSensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker diabetic fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV
DX Gram, AJ Hansen, CF Deacon, CL Brand, U Ribel, et al.
(2005) European Journal of Pharmacology, 509 p.211-217
Journal articlePlasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats
DX Gram, AJ Hansen, M Wilken, T Elm, O Svendsen, et al.
(2005) European Journal of Endocrinology, 153 p.963-969
Journal articleThe major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice
B Rolin, CF Deacon, RD Carr, Bo Ahrén
(2004) European Journal of Pharmacology, 494 p.283-288
Journal articleLow CSF leptin in female suicide attempters with major depression.
Sofie Westling, Bo Ahrén, Lil Träskman-Bendz, Åsa Westrin
(2004) Journal of Affective Disorders, 81 p.41-48
Journal articleLoss-of-Function Mutation of the Galanin Gene is Associated with Perturbed Islet Function in Mice.
Bo Ahrén, Giovanni Pacini, David Wynick, Nils Wierup, Frank Sundler
(2004) Endocrinology, 145 p.3190-3196
Journal articleHigh CSF-insulin in violent suicide attempters.
Sofie Westling, Bo Ahrén, Lil Träskman-Bendz, Åsa Westrin
(2004) Psychiatry Research, 129 p.249-255
Journal articleEffects of high-fat feeding and fasting on ghrelin expression in the mouse stomach.
Sophia Moesgaard, Bo Ahrén, Richard D Carr, Dorte X Gram, Christian L Brand, et al.
(2004) Regulatory Peptides, 120 p.261-267
Journal articleBody adiposity, insulin, and leptin in subgroups of peruvian amerindians.
Folke Lindgärde, Miyaray Benavente Ercilla, Laura Retamozo Correa, Bo Ahrén
(2004) High Altitude Medicine & Biology, 5 p.27-31
Journal articleSensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice.
Bo Ahrén
(2004) American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 286 p.269-272
Journal articleBasic toxicology and metabolism studies of 1,5-anhydro-D-fructose using bacteria, cultured mammalian cells, and rodents
SK Yu, Jie Mei, Bo Ahrén
(2004) Food and Chemical Toxicology, 42 p.1677-1686
Journal articleAged Transgenic Mice With Increased Glucocorticoid Sensitivity in Pancreatic beta-Cells Develop Diabetes.
Behrous Davani, Neil Portwood, Galina Bryzgalova, Martina Kvist Reimer, Thomas Heiden, et al.
(2004) Diabetes, 53 p.51-59
Journal articleTraditional versus agricultural lifestyle among Shuar women of the Ecuadorian Amazon: Effects on leptin levels
Folke Lindgärde, I Widen, M Gebb, Bo Ahrén
(2004) Metabolism, Clinical and Experimental, 53 p.1355-1358
Journal articleSerum uric acid in traditional Pacific Islanders and in Swedes.
S Lindeberg, L Cordain, Lennart Råstam, Bo Ahrén
(2004) Journal of Internal Medicine, 255 p.373-378
Journal articleGlucagon-like peptide-1 and islet lipolysis.
Maria Sörhede Winzell, Bo Ahrén
(2004) Hormone and Metabolic Research, 36 p.795-803
Journal articleDual action of adiponectin on insulin secretion in insulin-resistant mice.
Maria Sörhede Winzell, Rubén Nogueiras, Carlos Dieguez, Bo Ahrén
(2004) Biochemical and Biophysical Research Communications, 321 p.154-160
Journal articleThe high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.
Maria Sörhede Winzell, Bo Ahrén
(2004) Diabetes, 53 p.215-219
Journal articleBoth leptin and leptin-receptor are essential for apolipoprotein M expression in vivo.
Ning Xu, Peter Nilsson-Ehle, Maria Hurtig, Bo Ahrén
(2004) Biochemical and Biophysical Research Communications, 321 p.916-921
Journal articleBeta-Cell-Targeted Expression of a Dominant-Negative Mutant of Hepatocyte Nuclear Factor-1{alpha} in Mice: Diabetes Model with {beta}-Cell Dysfunction Partially Rescued by Nonglucose Secretagogues.
Maria Sörhede Winzell, Bo Ahrén, Claes B. Wollheim, Giovanni Pacini
(2004) Diabetes, 53 p.92-96
Journal articleGrowth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Katarina Link, Christian Moëll, Stanislaw Garwicz, Eva Cavallin-Ståhl, Jonas Björk, et al.
(2004) Journal of Clinical Endocrinology and Metabolism, 89 p.5003-5012
Journal articleInsulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance
E Rask, T Olsson, S Soderberg, JJ Holst, A Tura, et al.
(2004) Metabolism, Clinical and Experimental, 53 p.624-631
Journal articleInhibition of lipase activity and lipolysis in rat islets reduces insulin secretion.
Hindrik Mulder, Shumin Yang, Maria Sörhede Winzell, Cecilia Holm, Bo Ahrén
(2004) Diabetes, 53 p.122-128
Journal articleIncretin hormones and insulin secretion.
Bo Ahrén, J Gromada, O Schmitz
(2004) Hormone and Metabolic Research, 36 p.733-734
Journal article (letter)Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
T Nystrom, MK Gutniak, QM Zhang, F Zhang, JJ Holst, et al.
(2004) American Journal of Physiology: Endocrinology and Metabolism, 287 p.1209-1215
Journal articleInhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes.
Bo Ahrén, Mona Landin-Olsson, Per-Anders Jansson, Maria Svensson, David Holmes, et al.
(2004) Journal of Clinical Endocrinology and Metabolism, 89 p.2078-2084
Journal articleGLP-1 and extra-islet effects.
Bo Ahrén
(2004) Hormone and Metabolic Research, 36 p.842-845
Journal article reviewCorrelation of apolipoprotein M with leptin and cholesterol in normal and obese subjects.
Ning Xu, Peter Nilsson-Ehle, Bo Ahrén
(2004) Journal of Nutritional Biochemistry, 15 p.579-582
Journal articleTwelve- and 52-Week Efficacy of the Dipeptidyl Peptidase IV Inhibitor LAF237 in Metformin-Treated Patients With Type 2 Diabetes.
Bo Ahrén, Ramon Gomis, Eberhard Standl, David Mills, Anja Schweizer
(2004) Diabetes Care, 27 p.2874-2880
Journal articleGLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes.
Bo Ahrén, O Schmitz
(2004) Hormone and Metabolic Research, 36 p.867-876
Journal article reviewEstimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study
E Warensjo, JH Jansson, L Berglund, K Boman, Bo Ahrén, et al.
(2004) British Journal of Nutrition, 91 p.635-642
Journal articleImportance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies.
Bo Ahrén, Giovanni Pacini
(2004) European Journal of Endocrinology, 150 p.97-104
Journal article reviewInteractions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction
AM Thogersen, S Soderberg, JH Jansson, G Dahlen, K Boman, et al.
(2004) European Journal of Cardiovascular Prevention & Rehabilitation, 11 p.33-40
Journal articleBeta-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance and deranged glucose morphology.
Linda Härndahl, Nils Wierup, Sven Enerbäck, Hindrik Mulder, Vincent C Manganiello, et al.
(2004) Journal of Biological Chemistry, 279 p.15214-15222
Journal articleInhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?
CF Deacon, Bo Ahrén, JJ Holst
(2004) Expert Opinion on Investigational Drugs, 13 p.1091-1102
Journal article reviewSurvivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
Birgitta Bülow, Katarina Link, Bo Ahrén, Ann-Sofie Nilsson, Eva Marie Erfurth
(2004) Clinical Endocrinology, 61 p.683-691
Journal articleMilrinone efficiently potentiates insulin secretion induced by orally but not intravenously administered glucose in C57BL6J mice.
Eva Degerman, Vincent Manganiello, Jens J Holst, Bo Ahrén
(2004) European Journal of Pharmacology, 498 p.319-323
Journal articlePancreatic beta-Cell Lipotoxicity Induced by Overexpression of Hormone-Sensitive Lipase.
Maria Sörhede Winzell, Håkan Svensson, Sven Enerbäck, Kim Ravnskjaer, Susanne Mandrup, et al.
(2003) Diabetes, 52 p.2057-2065
Journal articlePACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas - Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets
GM Portela-Gomes, A Lukinius, Otto Ljungberg, S Efendic, Bo Ahrén, et al.
(2003) Regulatory Peptides, 113 p.31-39
Journal articleHigh leptin levels are associated with stroke
S Soderberg, B Stegmayr, C Ahlbeck-Glader, L Slunga-Birgander, Bo Ahrén, et al.
(2003) Cerebrovascular Diseases, 15 p.63-69
Journal articleLocal growth factors are beneficial for the autonomic reinnervation of transplanted islets in rats
Martina Kvist Reimer, SP Mokshagundam, K Wyler, Frank Sundler, Bo Ahrén, et al.
(2003) Pancreas, 26 p.392-397
Journal articleThe gender differences in growth hormone-binding protein and leptin persist in 80-year-old men and women and is not caused by sex hormones.
B Bülow, Bo Ahrén, S Fisker, Ove Dehlin, B Hagberg, et al.
(2003) Clinical Endocrinology, 59 p.6-482
Journal articleRandomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours
L Kolby, G Persson, S Franzen, Bo Ahrén
(2003) British Journal of Surgery, 90 p.687-693
Journal articleDual Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Isoproterenol on Lipid Metabolism and Signaling in Primary Rat Adipocytes.
Lina Åkesson, Bo Ahrén, Vincent C. Manganiello, Lena Stenson, Gudrun Edgren, et al.
(2003) Endocrinology, 144 p.5293-5299
Journal articleImproved beta -cell function after standardized weight reduction in severely obese subjects.
Marie Guldstrand, Bo Ahrén, Ulf Adamson
(2003) American Journal of Physiology: Endocrinology and Metabolism, 284 p.557-565
Journal articleLeptin is reduced in lean subjects with type 2 diabetes in bangladesh.
Mohammed Abu Sayeed, Abul Kalam Azad Khan, Hajera Mahtab, Khandaker Abdul Ahsan, Akhtar Banu, et al.
(2003) Diabetes Care, 26 p.547-547
Journal article (letter)Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes
B Olsson, M Bohlooly-Y, O Brusehed, OGP Isaksson, Bo Ahrén, et al.
(2003) American Journal of Physiology: Endocrinology and Metabolism, 285 p.504-511
Journal articleDeterminants of serum triglycerides and high-density lipoprotein cholesterol in traditional Trobriand Islanders: the Kitava Study.
S Lindeberg, Bo Ahrén, A Nilsson, L Cordain, Peter Nilsson-Ehle, et al.
(2003) Scandinavian Journal of Clinical & Laboratory Investigation, 63 p.175-180
Journal articleÅterta den kliniska forskningen - förslag till aktionsplan [Reclaim the clinical research--proposal to an action plan]
Bo Ahrén
(2003) Läkartidningen, 100 p.1361-1361
Journal articleCharacterization of GLP-1 effects on beta-cell function after meal ingestion in humans.
Bo Ahrén, Jens J Holst, Andrea Mari
(2003) Diabetes Care, 26 p.2860-2864
Journal articleSignals adapting the beta cells to changes in insulin sensitivity
Bo Ahrén, G Pacini
(2003) The metabolic syndrome: diabetes, obesity, hyperlipidemia and hypertension. Proceedings of the 8th European Symposium on Metabolism, 1253 p.105-113
Conference paperAlteration of the counterregulatory responses to insulin-induced hypoglycemia and of cognitive function after massive weight reduction in severely obese subjects
Marie Guldstrand, Bo Ahrén, Regina Wredling, Lars Backman, Per Eric Lins, et al.
(2003) Metabolism, Clinical and Experimental, 52 p.900-907
Journal articleDownregulation of islet hormone-sensitive lipase during long-term high-fat feeding.
Maria Sörhede Winzell, Cecilia Holm, Bo Ahrén
(2003) Biochemical and Biophysical Research Communications, 304 p.273-278
Journal articleInsulin sensitivity, insulin secretion, and glucose tolerance versus intima-media thickness in nondiabetic postmenopausal women.
Hillevi Larsson, Göran Berglund, Bo Ahrén
(2003) Journal of Clinical Endocrinology and Metabolism, 88 p.4791-4797
Journal articleImpaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes.
Xudong Huang, Allan Vaag, Emma A Nilsson, Mona Hansson, Bo Ahrén, et al.
(2003) Diabetes, 52 p.2411-2418
Journal articleDiabetes and impaired fasting glycemia in a rural population of Bangladesh
M Abu Sayeed, Hajera Mahtab, Parvin Akter Khanam, Zafar Abdul Latif, S M Keramat Ali, et al.
(2003) Diabetes Care, 26 p.1034-1039
Journal articleFat feeding impairs glycogen synthase activity in mice without effects on its gene expression.
Xudong Huang, Mona Hansson, Esa Laurila, Bo Ahrén, Leif Groop
(2003) Metabolism, Clinical and Experimental, 52 p.535-539
Journal articleIncreased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man.
Bo Ahrén, Ola Thorsson
(2003) Journal of Clinical Endocrinology and Metabolism, 88 p.1264-1270
Journal articleDose-dependent inhibition by ghrelin of insulin secretion in the mouse.
Martina Kvist Reimer, Giovanni Pacini, Bo Ahrén
(2003) Endocrinology, 144 p.916-921
Journal articleHormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact.
Hindrik Mulder, Maria Sorhede-Winzell, Juan Antonio Contreras, Malin Fex, Kristoffer Strom, et al.
(2003) Journal of Biological Chemistry, 278 p.36380-36388
Journal articleGut peptides and type 2 diabetes mellitus treatment.
Bo Ahrén
(2003) Current Diabetes Reports, 3 p.72-365
Journal articleAcylation stimulating protein stimulates insulin secretion.
Bo Ahrén, P J Havel, G Pacini, K Cianflone
(2003) International Journal of Obesity, 27 p.1037-1043
Journal articlePostnatally disturbed pancreatic islet cell distribution in human islet amyloid polypeptide transgenic mice
HY Wong, Bo Ahrén, CJM Lips, JWM Hoppener, Frank Sundler
(2003) Regulatory Peptides, 113 p.89-94
Journal articleThe association between leptin and proinsulin is lost with central obesity.
S Söderberg, Bo Ahrén, M Eliasson, B Dinesen, T Olsson
(2002) Journal of Internal Medicine, 252 p.140-148
Journal articleLong-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.
Martina Kvist Reimer, J J Holst, Bo Ahrén
(2002) European Journal of Endocrinology, 146 p.717-727
Journal articleInsulin-like growth factor II plays a central role in atherosclerosis in a mouse model.
Silvio Zaina, Linda Pettersson, Bo Ahrén, Lena Brånén, A Bassim Hassan, et al.
(2002) Journal of Biological Chemistry, 277 p.4505-4511
Journal articleEffects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice.
Martina Kvist Reimer, Frank Sundler, Bo Ahrén
(2002) Cell and Tissue Research, 307 p.203-209
Journal articleIslet function phenotype in gastrin-releasing Peptide receptor gene-deficient mice.
Kristin Persson, Giovanni Pacini, Frank Sundler, Bo Ahrén
(2002) Endocrinology, 143 p.3717-3726
Journal articleAbnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy
A Johansson, T Olsson, K Cederquist, H Forsberg, JJ Holst, et al.
(2002) European Journal of Endocrinology, 146 p.397-405
Journal articleImportant role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta -cell exocytosis and release of insulin.
Linda Härndahl, Xingjun Jing, Rosita Ivarsson, Eva Degerman, Bo Ahrén, et al.
(2002) Journal of Biological Chemistry, 277 p.37446-37455
Journal articleAltered beta-Cell Distribution of pdx-1 and GLUT-2 After a Short-Term Challenge With a High-Fat Diet in C57BL/6J Mice.
Martina Kvist Reimer, Bo Ahrén
(2002) Diabetes, 51 p.138-143
Journal articleDifferential impairment of glucagon responses to hypoglycemia, neuroglycopenia, arginine, and carbachol in alloxan-diabetic mice.
Bo Ahrén, Gerald J Taborsky, Peter J Havel
(2002) Metabolism, Clinical and Experimental, 51 p.12-19
Journal articleInhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
Bo Ahrén, Erik Simonsson, Hillevi Larsson, Mona Landin-Olsson, Hlin Torgeirsson, et al.
(2002) Diabetes Care, 25 p.869-875
Journal articleGender difference in the glucagon response to glucopenic stress in mice.
Sven Karlsson, Anton J W Scheurink, Bo Ahrén
(2002) American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 282 p.281-288
Journal articleAnti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.
Bo Ahrén, N Adner, J Svartberg, E Petrella, J J Holst, et al.
(2002) Diabetic Medicine, 19 p.790-792
Journal article (letter)Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice
Bo Ahrén, G Pacini
(2002) American Journal of Physiology: Endocrinology and Metabolism, 283 p.738-744
Journal articleResidual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
S Sjöberg, Bo Ahrén, J Bolinder
(2002) Journal of Internal Medicine, 252 p.342-351
Journal articleThe neuropeptide PACAP contributes to the glucagon response to insulin-induced hypoglycaemia in mice.
K Persson, Bo Ahrén
(2002) Acta Physiologica Scandinavica, 175 p.25-28
Journal articleInterleukin-6-deficient mice develop mature-onset obesity
V Wallenius, K Wallenius, Bo Ahrén, M Rudling, H Carlsten, et al.
(2002) Nature Medicine, 8 p.75-79
Journal articleAdrenal incidentaloma - experience of a standardized diagnostic programme in the Swedish prospective study.
B Bülow, Bo Ahrén
(2002) Journal of Internal Medicine, 252 p.239-246
Journal articleQuantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women.
Bo Ahrén, Hillevi Larsson
(2002) Diabetes, 51 p.202-211
Journal articleReduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan.
M Abdelgadir, M Elbagir, M Eltom, C Berne, Bo Ahrén
(2002) Metabolism, Clinical and Experimental, 51 p.304-306
Journal articleAutonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia
GJ Taborsky, Bo Ahrén, TO Mundinger, Q Mei, PJ Havel
(2002) Diabetes, Nutrition and Metabolism. Clinical and Experimental, 15 p.318-322
Journal articleRole of islet amyloid in type 2 diabetes mellitus: consequence or cause?
JWM Hoppener, MG Nieuwenhuis, TM Vroom, Bo Ahrén, CJM Lips
(2002) Molecular and Cellular Endocrinology, 197 p.205-212
Journal articleAutonomic neuropathy is associated with impaired pancreatic polypeptide and neuropeptide Y responses to insulin-induced hypoglycaemia in Type I diabetic patients.
J Bolinder, S Sjoberg, A Persson, Bo Ahrén, G Sundkvist
(2002) Diabetologia, 45 p.1043-1044
Journal article (letter)Testosterone and diurnal rhythmicity of leptin, TNF-alpha and TNF-II receptor in insulin-resistant myotonic dystrophy patients
A Johansson, Bo Ahrén, H Forsberg, T Olsson
(2002) International Journal of Obesity, 26 p.1386-1392
Journal articleLong-term leptin treatment of ob/ob mice improves glucose-induced insulin secretion
A Khan, S Narangoda, Bo Ahrén, Cecilia Holm, Frank Sundler, et al.
(2001) International Journal of Obesity, 25 p.816-821
Journal articleBeta cell adaptation to dexamethasone-induced insulin resistance in rats involves increased glucose responsiveness but not glucose effectiveness
Sven Karlsson, Björn Ostlund, Ulrika Myrsen-Axcrona, Frank Sundler, Bo Ahrén
(2001) Pancreas, 22 p.148-156
Journal articleDirect cytoplasmic CA(2+) responses to gastrin-releasing peptide in single beta cells
Sven Karlsson, Frank Sundler, Bo Ahrén
(2001) Biochemical and Biophysical Research Communications, 280 p.610-614
Journal articleDifferential glucose responsitivity in insulin-producing cell lines derived from the INS-1 line is associated with altered Ca2+dynamics and Ca2+-evoked exocytosis
S Yang, Bo Ahrén, Erik Renström, E Hohmeier, C B Newgard, et al.
(2001) Diabetologia, 44 p.134-134
Journal articleIncreased leptin and tumour necrosis factor alpha per unit fat mass in hypopituitary women without growth hormone treatment
B. Bulow, Bo Ahrén, Eva Marie Erfurth
(2001) European Journal of Endocrinology, 145 p.737-742
Journal articleOverexpression of hormone-sensitive lipase in beta-cells results in blunted glucose stimulated insulin secretion after feeding mice a high-fat diet
Maria Sörhede Winzell, H Svensson, S Enerback, Bo Ahrén, Cecilia Holm
(2001) Diabetologia, 44 p.6-6
Journal articleLong-standing hyperglycemia in C57BL/6J mice does not affect retinal glutathione levels or endothelial/pericyte ratio in retinal capillaries
Carl-David Agardh, Elisabet Agardh, Björn Hultberg, Bo Ahrén
(2000) Journal of Diabetes and its Complications, 14 p.146-153
Journal articleThe relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy [10]
Anders Gottsäter, Bo Ahrén, Göran Sundkvist
(1999) Diabetes Care, 22 p.1913-1914
Journal article (letter)Habitual dietary intake versus glucose tolerance, insulin sensitivity and insulin secretion in postmenopausal women
Hillevi Larsson, S. Elmstǎhl, G. Berglund, B. Ahrén
(1999) Journal of Internal Medicine, 245 p.581-591
Journal articleHormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells
Hindrik Mulder, Lena Stensson Holst, Håkan Svensson, Eva Degerman, Frank Sundler, et al.
(1999) Diabetes, 48 p.228-232
Journal articleEvidence for leptin regulation of food intake in humans
Hillevi Larsson, Sölve Elmståhl, Göran Berglund, Bo Ahrén
(1998) Journal of Clinical Endocrinology and Metabolism, 83 p.4382-4385
Journal articleProtein kinase B is expressed in pancreatic beta cells and activated upon stimulation with insulin-like growth factor I
Lena Stenson, Hindrik Mulder, V Manganiello, Frank Sundler, Bo Ahrén, et al.
(1998) Biochemical and Biophysical Research Communications, 250 p.181-186
Journal articleBone mineral density in patients with Crohn's disease during long-term treatment with azathioprine
Claes-Henrik Florén, Bo Ahrén, M Bengtsson, Jacek Bartosik, Karl Obrant
(1998) Journal of Internal Medicine, 243 p.123-126
Journal articleIntraoperative secretion of intact parathyroid hormone and amino-terminal parathyroid hormone fragments from normal parathyroid glands associated with solitary parathyroid adenoma
A Bergenfelz, B Ahrén
(1997) World Journal of Surgery, 21 p.30-35
Journal articleHypertyroxinemi efter parathyreoideakirurgi. Ej ovanligt transient symtomgivande tillstånd
B Ahrén, A Bergenfelz
(1995) Läkartidningen, 92 p.90-2393
Journal articleImmunoheterogeneity of parathyroid hormone pre- and postoperatively in primary hyperparathyroidism
A Bergenfelz, S Valdermarsson, B Ahrén
(1995) Langenbecks Archiv für Chirurgie, 380 p.24-119
Journal articleEffects of minor increase in serum calcium on the immunoheterogeneity of parathyroid hormone in healthy subjects and in patients with primary hyperparathyroidism
B Ahrén, A Bergenfelz
(1995) Hormone Research, 43 p.9-294
Journal articleImmunoheterogeneity of parathyroid hormone after surgery for primary hyperparathyroidism
A Bergenfelz, S Valdermarsson, B Ahrén
(1994) Clinica Chimica Acta, 231 p.45-139
Journal articleFunctional recovery of the parathyroid glands after surgery for primary hyperparathyroidism
A Bergenfelz, S Valdermarsson, B Ahrén
(1994) Surgery, 116 p.36-827
Journal articleIntraoperative monitoring of intact PTH during surgery for primary hyperparathyroidism
A Bergenfelz, A Isaksson, B Ahrén
(1994) Langenbecks Archiv für Chirurgie, 379 p.3-50
Journal articleSerum levels of thyrotropin are decreased by oral calcium in healthy subjects but not in patients with primary hyperparathyroidism
A Bergenfelz, B Ahrén
(1994) Hormone Research, 42 p.7-273
Journal articleHyperthyroxinemia after surgery for primary hyperparathyroidism
A Bergenfelz, B Ahrén
(1994) Langenbecks Archiv für Chirurgie, 379 p.81-178
Journal articleSuppressibility of serum levels of PTH by calcium in the immediate postoperative period after surgery for primary hyperparathyroidism
A Bergenfelz, B Ahrén
(1993) World Journal of Surgery, 17 p.10-806
Journal articlePostoperative studies on parathyroid hormone secretion in patients operated on for primary hyperparathyroidism
A Bergenfelz, N E Nordén, B Ahrén
(1993) Clinica Chimica Acta, 219 p.67-77
Journal articleIntraoperativ bestämning av intakt parathormon. Hjälp för kirurgen vid primär hyperparatyreoidism
A Bergenfelz, A Isaksson, B Ahrén
(1993) Läkartidningen, 90 p.4-2973
Journal articleParathyroid hormone secretion after operation for primary hyperparathyroidism
A Bergenfelz, N Nordén, B Ahrén
(1993) Surgery, 113 p.54-649
Journal articlePotential clinical use of the EDTA-infusion test
B Ahrén, A Bergenfelz
(1993) European Journal of Clinical Chemistry and Clinical Biochemistry, 31 p.8-353
Journal articleCalcium metabolism after hemithyroidectomy
A Bergenfelz, B Ahrén
(1993) Hormone Research, 39 p.56-60
Journal articleSuppression by calcium of serum levels of intact parathyroid hormone in patients with primary hyperparathyroidism
A Bergenfelz, S Valdermarsson, B Ahrén
(1993) Hormone Research, 39 p.51-146
Journal articlePrediction of changes in bone density after operation for primary hyperparathyroidism
A Bergenfelz, B Lindergård, B Ahrén
(1993) Annales Chirurgiae et Gynaecologiae, 82 p.9-245
Journal articleLarge vein sampling for intact parathyroid hormone in preoperative localization of enlarged parathyroid glands
A Bergenfelz, C Lundstedt, H Stridbeck, B Ahrén
(1992) Acta radiologica (Stockholm, Sweden : 1987), 33 p.31-528
Journal articleSurgery for primary hyperparathyroidism performed under local anaesthesia
A Bergenfelz, L Algotsson, B Ahrén
(1992) British Journal of Surgery, 79 p.4-931
Journal articleBiochemical variables associated with bone density in patients with primary hyperparathyroidism
A Bergenfelz, B Lindergård, B Ahrén
(1992) European Journal of Surgery, Acta Chirurgica, 158 p.6-473
Journal articleThallium-technetium subtraction scintigraphy of enlarged parathyroid glands after calcitonin stimulation of parathyroid hormone secretion
A Bergenfelz, J Tennvall, B Ahrén
(1992) Acta radiologica (Stockholm, Sweden : 1987), 33 p.22-319
Journal articleSerum osteocalcin levels do not change during rapidly induced hypercalcemia in healthy subjects
A Bergenfelz, B Ahrén
(1992) Hormone Research, 37 p.29-32
Journal articleMeasurement of intact parathyroid hormone in the diagnosis of hyperparathyroidism
A Bergenfelz, S Valdermarsson, B Ahrén
(1991) Acta Endocrinologica, 125 p.74-668
Journal articlePreoperative localization of enlarged parathyroid glands with ultrasonically guided fine needle aspiration for parathyroid hormone assay
A Bergenfelz, L Forsberg, Esbjörn Hederström, B Ahrén
(1991) Acta radiologica (Stockholm, Sweden : 1987), 32 p.5-403
Journal articleIntact parathyroid hormone assay is superior to mid region assay in the EDTA-infusion test in hyperparathyroidism
A Bergenfelz, N E Nordén, B Ahrén
(1991) Clinica Chimica Acta, 197 p.35-229
Journal articleIntraoperative fall in plasma levels of intact parathyroid hormone after removal of one enlarged parathyroid gland in hyperparathyroid patients
A Bergenfelz, N E Nordén, B Ahrén
(1991) Acta Chirurgica Scandinavica, 157 p.12-109
Journal articleMonoamines in pancreatic islets of guinea pig, hamster, rat, and mouse determined by high performance liquid chromatography
Ingmar Lundquist, Bo Ahrén, Christer Hansson, Rolf Håkanson
(1989) Pancreas, 4 p.662-667
Journal articleDietary fibre in type II diabetes
N G Asp, Carl-David Agardh, Bo Ahrén, I Dencker, C G Johansson, et al.
(1982) Acta medica Scandinavica. Supplementum, 210 p.47-50
Journal articleDiabetes och trafikkort. Studier av insulin- och C-peptidnivåer
Carl-David Agardh, Bo Ahrén, P O Bitzen, Bengt Scherstén
(1981) Läkartidningen, 78 p.236-240
Journal articleImmunoreactive insulin and C-peptide responses to various insulin secretory stimuli in subjects with type 2 diabetes and in control subjects during continuous glucose monitoring
Bo Ahrén, Bengt Scherstén, Carl-David Agardh, Ingmar Lundquist
(1981) Acta Medica Scandinavica, 210 p.337-348
Journal article